Itaconate controls the severity of pulmonary fibrosis

Autor: Toby M. Maher, Brendan O'Sullivan, Peter McErlean, Adam J. Byrne, John M. Halket, Peter Saunders, Shaun Kingston, Simone A. Walker, Joseph E. Powell, Philip L. Molyneaux, Robert Gray, Clare M. Lloyd, Daniel C. Chambers, Patricia P. Ogger, Emily Calamita, Poonam Ghai, Richard J. Hewitt, Gesa J. Albers
Přispěvatelé: Asthma UK, Wellcome Trust, National Heart & Lung Institute Foundation
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
Adoptive cell transfer
Carboxy-Lyases
Severity of Illness Index
Idiopathic pulmonary fibrosis
chemistry.chemical_compound
Mice
0302 clinical medicine
Fibrosis
Pulmonary fibrosis
Lung
Cells
Cultured

Mice
Knockout

medicine.diagnostic_test
General Medicine
respiratory system
Middle Aged
Adoptive Transfer
Healthy Volunteers
medicine.anatomical_structure
030220 oncology & carcinogenesis
Female
Bronchoalveolar Lavage Fluid
Adult
Immunology
Primary Cell Culture
Bleomycin
Article
03 medical and health sciences
In vivo
Administration
Inhalation

Bronchoscopy
Macrophages
Alveolar

medicine
Animals
Humans
Hydro-Lyases
Aged
business.industry
Succinates
Fibroblasts
medicine.disease
Idiopathic Pulmonary Fibrosis
respiratory tract diseases
Disease Models
Animal

030104 developmental biology
Bronchoalveolar lavage
chemistry
Case-Control Studies
business
Zdroj: Sci Immunol
ISSN: 2470-9468
Popis: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease in which airway macrophages (AMs) play a key role. Itaconate has emerged as a mediator of macrophage function, but its role during fibrosis is unknown. Here, we reveal that itaconate is an endogenous antifibrotic factor in the lung. Itaconate levels are reduced in bronchoalveolar lavage, and itaconate-synthesizing cis-aconitate decarboxylase expression (ACOD1) is reduced in AMs from patients with IPF compared with controls. In the murine bleomycin model of pulmonary fibrosis, Acod1-/- mice develop persistent fibrosis, unlike wild-type (WT) littermates. Profibrotic gene expression is increased in Acod1-/- tissue-resident AMs compared with WT, and adoptive transfer of WT monocyte-recruited AMs rescued mice from disease phenotype. Culture of lung fibroblasts with itaconate decreased proliferation and wound healing capacity, and inhaled itaconate was protective in mice in vivo. Collectively, these data identify itaconate as critical for controlling the severity of lung fibrosis, and targeting this pathway may be a viable therapeutic strategy.
Databáze: OpenAIRE